FDA Clearance Tracker · P990065
SIR-SPHERES
Last checked: Nov 19, 2026Latest source record: Mar 5, 2002 (this decision)Source: openFDAMethods & limitations
Decided
Mar 5, 2002
Approved
Time to decision
862 days
Received Oct 25, 1999. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P990065
- Device name
- SIR-SPHERES
- Applicant
- Sirtex Medical, Inc.
- Applicant location
- Woburn, MA
- Received
- Oct 25, 1999
- Decided
- Mar 5, 2002
- Decision
- Approved
- Supplements
- 14 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Microspheres radionuclide (NAW)
- Device class
- Class III
- Specialty
- Radiology & Imaging
FDA's approval statement
As written in FDA's record.
APPROVAL FOR SIR-SPHERES. THE DEVICE IS INDICATED FOR THE TREATMENT OF UNRESECTABLE METASTATIC LIVER TUMORS FROM PRIMARY COLORECTAL CANCER WITH ADJUVANT INTRA-HEPATIC ARTERY CHEMOTHERAPY (IHAC) OF FUDR (FLOXURIDINE).
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code NAW (Microspheres radionuclide).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Sirtex Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SIR-Spheres Y-90 resin microspheresPMA supplement
P990065-S014 · Decided Jul 1, 2025 · 532 days after receipt · Panel Track
Device type: Microspheres radionuclide (NAW) · Radiology & Imaging
P220020 · Decided Apr 4, 2023 · 180 days after receipt
Device type: Embolization Agent, Vascular (QVG) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.